Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
9.22
+0.20 (2.22%)
Jul 10, 2026, 3:04 PM CST
SHE:000403 Market Cap
SHE:000403 has a market cap or net worth of 8.76 billion as of July 10, 2026. Its market cap has decreased by -49.42% in one year.
Market Cap
8.76B
Enterprise Value
8.84B
Revenue
2.60B
Ranking
n/a
PE Ratio
25.91
Stock Price
9.22
Market Cap Chart
Since September 23, 1996, SHE:000403's market cap has increased from 230.36M to 8.76B, an increase of 3,703.87%. That is a compound annual growth rate of 12.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 8.76B | -32.65% |
| Dec 31, 2025 | 13.01B | -15.77% |
| Dec 31, 2024 | 15.45B | -22.60% |
| Dec 29, 2023 | 19.96B | 19.73% |
| Dec 30, 2022 | 16.67B | -18.85% |
| Dec 31, 2021 | 20.54B | 9.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 9.77B |
| Chengdu Easton Biopharmaceuticals | 8.98B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.94B |
| Nanjing Vazyme Biotech | 8.92B |
| Chongqing Genrix Biopharmaceutical | 8.77B |
| Sino Biological,Inc. | 8.36B |
| Vcanbio Cell & Gene Engineering Corp., | 8.05B |
| Acrobiosystems | 8.03B |